Reuters logo
BRIEF-Madrigal Pharmaceuticals Q4 loss per share $0.67
April 3, 2017 / 11:50 AM / 6 months ago

BRIEF-Madrigal Pharmaceuticals Q4 loss per share $0.67

April 3 (Reuters) - Madrigal Pharmaceuticals Inc

* Madrigal Pharmaceuticals reports 2016 fourth quarter and year-end financial results, reviews key corporate achievements and provides update on lead clinical-stage compound, MGL-3196

* Qtrly loss per share $0.67 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below